nicergoline

The drug is used for acute and chronic cerebral circulation disorders caused by atherosclerosis, thrombosis, or vascular embolism, as well as for transient ischemic attacks. It is also prescribed for headaches and as an adjunct treatment for systemic arterial hypertension.

Form: tablets, film-coated

ATC: C04AE02

Manufacturer: PJSC "Halychpharm"

The drug is prescribed for acute and chronic cerebral circulation disorders (due to atherosclerosis, thrombosis, or embolism of the vessels), transient ischemic attacks, headaches, and as adjunctive therapy for arterial hypertension.

Form: lyophilisate for solution for injection

ATC: C04AE02

Manufacturer: Farmex Group LLC

The drug is indicated for the treatment of post-stroke conditions, vascular dementia (multi-infarct dementia), as well as degenerative conditions associated with dementia (e.g., Alzheimer's or Parkinson's disease).

Form: tablets, film-coated

ATC: C04AE02

Manufacturer: Pfizer Italia S.r.l.

The drug is prescribed for acute and chronic cerebral circulation disorders (due to atherosclerosis, thrombosis, or embolism), transient ischemic attacks, headaches, and as adjunctive treatment for systemic arterial hypertension.

Form: tablets, sugar-coated

ATC: C04AE02

Manufacturer: Pfizer Italia S.r.l.

The drug is indicated for acute and chronic cerebral circulation disorders (due to atherosclerosis, thrombosis, or embolism), transient ischemic attacks, headaches, and as adjunctive treatment for systemic arterial hypertension.

Form: tablets, sugar-coated

ATC: C04AE02

Manufacturer: Pfizer Italia S.r.l.

The drug is indicated for acute and chronic cerebral circulation disorders (due to atherosclerosis, thrombosis, or embolism of the vessels), transient ischemic attacks, headaches, and as adjunctive therapy for arterial hypertension.

Form: lyophilisate for solution for injection

ATC: C04AE02

Manufacturer: Vaiet Pharma, S.A. (manufacturing, quality control, primary packaging, batch release for powder)